Fortaleza Asset Management’s Kyntra Bio KYNB Stock Holding History

Fortaleza Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$151K	Sell	96 -44	-31%	-$57.4K	1.22%	27
2018 Q1	$161K	Hold	140	–	–	0.98%	52
2017 Q4	$165K	Buy	140 +68	+94%	+$85.3K	1.04%	52
2017 Q3	$96K	Sell	72 -34	-32%	-$35.8K	0.18%	139
2017 Q2	$85K	Buy	+106	New	+$73.8K	0.16%	146
2015 Q2	–	Sell	-213	Closed	-$167K	–	203
2015 Q1	$167K	Sell	213 -315	-60%	-$244K	0.09%	149
2014 Q4	$361K	Buy	+528	New	+$340K	0.17%	156

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fortaleza Asset Management's KYNB Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Kyntra Bio (KYNB) stake by 31% in Q2 2018, selling an estimated $57.4K and leaving 96 shares worth $151K. The position accounts for 1.22% of the portfolio, ranked #27.

Fortaleza Asset Management first reported a position in KYNB in Q4 2014 and has held it in 7 quarters since. The position peaked at $361K in Q4 2014. 192 funds tracked by Wall St. Rank hold KYNB as of Q2 2018.

Fortaleza Asset Management held 96 shares of Kyntra Bio worth $151K as of Q2 2018.
Fortaleza Asset Management sold 44 Kyntra Bio shares in Q2 2018, an estimated $57.4K.
Kyntra Bio made up 1.22% of Fortaleza Asset Management's portfolio in Q2 2018, its #27 holding.
Fortaleza Asset Management first reported a position in Kyntra Bio in Q4 2014 and has held it in 7 quarters since.
Fortaleza Asset Management's Kyntra Bio position peaked at $361K in Q4 2014.
192 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.